Friday, September 28, 2018 Daily Archives

Minimizing Resources in Developing Commercial Virus Filtration Processes with Planova BioEX

by

This webcast features: Roya Dayani, Senior Product Manager, Asahi Kasei Bioprocess Europe Establishing a virus filtration step in biopharmaceutical development and manufacturing process may require a large amount of resources (i.e., time, manpower and cost). These can be minimized with swift process development, smooth scale-up and worry-free operations. In this webinar Asahi Kasei Bioprocess will answer the question “What are the main requirements for a virus filter at each phase?â€. You will learn through different case studies the filtration performances…

September 28, 2018

Emergent extends ABEC disposable deal to equip Maryland plant

by

Emergent BioSolutions has extended its partnership with vendor ABEC and added a dual purpose single-use system at its site in Baltimore, Maryland. ABEC has shipped a custom designed CSR (Custom Single Run) dual purpose single-use system to Emergent’s Bayview facility, intended for large scale microbial fermentation and mammalian cell culture. “A CSR dual purpose system can operate as a 750 L production microbial fermenter or as a 500L seed bioreactor for Emergent’s 4,000 L CSR bioreactor,†ABEC spokesperson Susan Cooper-Curcio…

September 28, 2018

Hey Praesto: Purolite opens Protein A plant, opens up resin market

by

Purolite says its 100,000 L facility will give biomanufacturers the “only credible alternative†for the supply of agarose Protein A resin. The firm claims its chromatography resins can reduce costs by up to 70% compared to the market leading product. This week, Purolite Life Sciences cut the ribbon at a manufacturing facility in Llantrisant Business Park, Wales capable of producing 100,000L of its Praesto range of agarose Protein A affinity resins. Supported by a Welsh government grant, the facility is…

September 28, 2018